2021
DOI: 10.1007/s10147-021-01933-9
|View full text |Cite
|
Sign up to set email alerts
|

Jab1/Cops5: a promising target for cancer diagnosis and therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 65 publications
1
10
0
Order By: Relevance
“…Previous studies have shown that the expression level of Jab1 is elevated in many tumors, including NPC (16), which is consistent with the findings of our study. We found that Jab1 is elevated in the tumor cell-enriched regions compared with the normal epithelial-enriched regions.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Previous studies have shown that the expression level of Jab1 is elevated in many tumors, including NPC (16), which is consistent with the findings of our study. We found that Jab1 is elevated in the tumor cell-enriched regions compared with the normal epithelial-enriched regions.…”
Section: Discussionsupporting
confidence: 93%
“…One molecular mechanism leading to NPC tumorigenesis involves the fifth component of the COP9 signalosome complex (Csn5, COPS5 or Jab1). Jab1 acts as a modulator of intracellular signaling and affects cellular proliferation, apoptosis, and DNA damage response by interacting with several key regulatory proteins and affecting these proteins' subcellular localization, degradation, phosphorylation, and deneddylation (16). Jab1 has been reported to be associated with cuproptosis related genes.…”
Section: Introductionmentioning
confidence: 99%
“…A study combining expression analysis in patient biopsies with functional in vitro and in vivo investigations demonstrated that let-7d regulates cell growth and invasion in breast cancer, and also inhibits Jab1 (Jun activation domain-binding protein 1) protein expression [ 57 ]. Jab1 is a component of the COP9 signalosome protein complex that regulates fundamental cellular processes linked to the ubiquitin–proteasome system [ 58 ]. It acts as a docking interface for protein kinases, thereby affecting numerous signaling pathways relevant to tumor progression, including p53, p27 AP-1 and Smad proteins active in TGF-β1 signaling [ 59 , 60 , 61 ].…”
Section: Let-7d and Breast Cancermentioning
confidence: 99%
“…Several reports have explained the association of Jab1/p27 inverse correlation with the phytocompound-mediated apoptosis induction in cancer cells [37][38][39][40]. Jab1 executes its biological role by promoting the degradation of several tumor suppressor genes including p27 and p53 via translocating them from the nucleus to cytoplasm [41,42].…”
Section: Discussionmentioning
confidence: 99%